Basilea Pharmaceutica
Switzerland - AllschwilBiotechnology
Focus: Basilea Pharmaceutica is a Swiss public biotech company focused on specialty therapeutics across oncology, infectious diseases, immunology, metabolic diseases, and gastroenterology, with a particular emphasis on topical formulations.
Profile data last refreshed 1h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
1-1 this month
Stable — net -1 jobs in 30d
0 added, 1 removed. Backfill posture.
Should You Work at Basilea Pharmaceutica?
AI assessmentBasilea offers exposure to late-stage infectious disease and oncology programs with European regulatory advantages, but severely limited hiring and opaque financials present execution risk for career growth.
Why Work Here
- Diversified pipeline across 5 therapeutic areas with 9 active programs, including 3 Phase 3 candidates (ceftobiprole, alitretinoin, fosmanogepix) positioned for near-term catalysts
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Help build intelligence for Basilea Pharmaceutica
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.